Fundz

Check-Cap Ltd

Biotechnology, Healthcare, Health Care

Check-Cap (NASDAQ: CHEK) is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening through the introduction of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer and enable early intervention and cancer prevention.

Key facts

Employees
29
Industries
Biotechnology, Healthcare, Health Care
Status
Public (MBAI)
Website
check-cap.com
LinkedIn
Company page

Recent activity at Check-Cap Ltd

Check-Cap Ltd funding history

DateRoundAmount
May 2020Seed$3.0M
May 2020Seed$4.5M
May 2020Seed$4.0M
Nov 2017Seed$2.1M
Jun 2017Seed$2.7M

Leadership

  • Steven Hanley, Director
  • Clara Ezed, Director
  • Mary Gorman, Director
  • XiangQian Lin, Director
  • Yuval Yanai, Director
  • Steven Hanley, Director
  • Clara Ezed, Director
  • Mary Gorman, Director
  • XiangQian Lin, Director
  • Yuval Yanai, Director
  • Steven Hanley, Director
  • Clara Ezed, Director

Verified email and direct lines for Check-Cap Ltd’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Check-Cap Ltd in the news

Companies similar to Check-Cap Ltd

  • BrainScope · Biotechnology, Healthcare, Health Care, Health Diagnostics, Medical, Medical Device
  • Clarapath · Biotechnology, Healthcare, Health Care, Health Diagnostics, Medical, Medical Device
  • AliveCor, Inc. · Biotechnology, Healthcare, Health Care, Health Diagnostics, Medical, Medical Device
  • Ayati Devices · Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
  • MiMARK Diagnostics · Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device

About Check-Cap Ltd: questions and answers

What does Check-Cap Ltd do?

Check-Cap (NASDAQ: CHEK) is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening through the introduction of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer and enable early intervention and cancer prevention.

How many employees does Check-Cap Ltd have?

Check-Cap Ltd has about 29 employees.

Has Check-Cap Ltd raised funding?

Yes. Fundz has recorded 5 funding events for Check-Cap Ltd. The most recent, Seed of $3.0M, was in May 2020.

What is the latest news on Check-Cap Ltd?

On Jun 29, 2026, Check-Cap to merge with MBody AI for tech expansion

Is Check-Cap Ltd a public company?

Yes. Check-Cap Ltd is publicly traded under the ticker MBAI.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Check-Cap Ltd across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.